BIOHYBRITE Decoding and designing biomolecular systems with hybrid DNA:RNA: protein nanotechnology
- Coordinator
- Ludwig-Maximilians-Universitaet Muenchen, Germany
- Runs
- 1 March 2026 to 28 February 2030
- Status
- Running
- EU funding
- €4.5m
- Total cost
- —
- Partners
- 18 organisations in 7 countries
- Type
- Marie Skłodowska-Curie Action
- Grant agreement
- 101227379
What the project is doing
In the project's own words, from its summary on CORDIS.
In recent years, we have witnessed the emergence of DNA nanotechnology that enables self-assembly of some of the largest and most complex functional molecular systems to date. Simultaneously, RNA plays a pivotal role in nanomedical advancements, notably in the development of Covid-19 vaccines. Moreover, utilising deep learning to address the protein prediction challenge paves the way for de novo protein design in the realm of protein nanotechnology.
BioHYBRITE is designed as an innovative and pioneering training network, with the unique vision of developing the next-generation of biomolecular systems based on integrated hybrid DNA:RNA:Protein nanotechnology. BioHYBRITE brings together leading European research groups for combining all sequence-based biomolecules into a unified bottom-up nanobiotechnology. The consortium will collectively build modular platforms with a range of novel functions for molecular sensing, information processing and actuation.
Thereby the collaboration synergizes a unique toolset of theoretical and experimental methods for designing and understanding the hybrid systems including state-of-the-art single-molecule and superresolution technology. The outcome will be a new generation of young experts in the development of smart, self-assembling, hybrid nano-devices that detect and act in complex biomolecular systems and will form the basis of a future nanomedicine based on active molecular systems.
The doctoral candidates will be trained in all aspects for programmed design of hybrid bottom-up nanostructures, their characterization and use for decoding and interacting with biomolecular systems, thereby fully benefiting from the synergies of the different partners’ competences. The innovative and applied focus is supported by the involvement of pioneering industrial partners providing complementary skills training as well as intersectoral exchange of the doctoral candidates with a potential high impact in future exploitations.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Ludwig-Maximilians-Universitaet Muenchen | Planegg | Germany | Coordinator |
| Interuniversitair Micro-Electronica Centrum | Leuven | Belgium | Associatedpartner |
| Gattaquant GmbH | Munich | Germany | Participant |
| Massive Photonics GmbH | München | Germany | Associatedpartner |
| Nanion Technologies GmbH | Munchen | Germany | Associatedpartner |
| Roche Diagnostics GmbH | Mannheim | Germany | Associatedpartner |
| Technische Universitaet Muenchen | Muenchen | Germany | Participant |
| Technische Universitat Dortmund | Dortmund | Germany | Participant |
| Tartu Ulikool | Tartu | Estonia | Participant |
| Agencia Estatal Consejo Superior De Investigaciones Cientificas | Madrid | Spain | Participant |
| Universidad Autonoma De Madrid | Madrid | Spain | Associatedpartner |
| Centre National De La Recherche Scientifique CNRS | Paris | France | Participant |
| Universite De Montpellier | Montpellier | France | Associatedpartner |
| Scuola Internazionale Superiore Di Studi Avanzati Di Trieste | Trieste | Italy | Participant |
| Universita Degli Studi Di Modena E Reggio Emilia | Modena | Italy | Participant |
| Universita Degli Studi Di Roma Tor Vergata | Roma | Italy | Participant |
| Imperial College of Science Technology and Medicine | London | United Kingdom | Participant |
| The Chancellor Masters and Scholars of the University of Cambridge | Cambridge | United Kingdom | Participant |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI